Keywords: lobucavir, starts, phase, iii, trials, hbv, bristol-myers

Lobucavir Starts Phase III Trials In HBV

Article | 11 November 1998

Bristol-Myers Squibb has started a large-scale, Phase III trial ofonce-daily, oral lobucavir in patients with chronic hepatitis B virus infection, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Nystatin

Go to drug listing